# OnCo record lymphoma-ev-randomised-evidence-for-the-t-cell-lymphomas (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/lymphoma-ev-randomised-evidence-for-the-t-cell-lymphomas/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "lymphoma-ev-randomised-evidence-for-the-t-cell-lymphomas" ;
  schema:name "Randomised evidence for the T-cell lymphomas, including the ones that are not in Europe or North America"@en ;
  schema:alternateName "Randomised trials in peripheral T-cell lymphoma"@en, "International trials for NK/T-cell and adult T-cell lymphoma"@en ;
  schema:description "Adult T-cell leukaemia has had one randomised trial, in 1998. Most T-cell lymphoma treatment rests on single-arm studies, and the diseases concentrated outside Europe and North America have the least evidence of all."@en ;
  schema:url <https://onco.cc/ideas/lymphoma-ev-randomised-evidence-for-the-t-cell-lymphomas/> ;
  schema:dateModified "2026-10-01"^^xsd:date ;
  onco:tag "lymphoma-evidence" ;
  onco:related <https://onco.cc/roadmaps/lymphoma-roadmap/> ;
  onco:cancers <https://onco.cc/cancers/peripheral-t-cell-lymphoma/>, <https://onco.cc/cancers/angioimmunoblastic-t-cell-lymphoma/>, <https://onco.cc/cancers/cutaneous-t-cell-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/chemotherapy/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:targets <https://onco.cc/targets/cd30/> ;
  onco:drugs <https://onco.cc/drugs/brentuximab-vedotin/>, <https://onco.cc/drugs/asparaginase/>, <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/vincristine/>, <https://onco.cc/drugs/prednisone/>, <https://onco.cc/drugs/etoposide/> ;
  onco:trials <https://onco.cc/trials/jcog9801/>, <https://onco.cc/trials/smile-enktl/>, <https://onco.cc/trials/echelon-2/>, <https://onco.cc/trials/alcanza/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-rare-cancers/>, <https://onco.cc/bottlenecks/b-trial-enrolment/>, <https://onco.cc/bottlenecks/b-global-access/>, <https://onco.cc/bottlenecks/b-regulatory-fragmentation/>, <https://onco.cc/bottlenecks/b-incentive-misalignment/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-jcog9801-vcap-amp-vecp-adult-t-cell-leukaemia-jco-2007/>, <https://onco.cc/key-papers/paper-smile-chemotherapy-nk-t-cell-lymphoma-jco-2011/>, <https://onco.cc/key-papers/paper-horwitz-lancet/> .